Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Zint, K.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(11)
+
-
Availability
Open access
(4)
+
-
Metadata Only
(7)
+
-
Creation Date
2017
(3)
+
-
2018
(2)
+
-
2020
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(11)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(11)
+
-
Topic
Atrial fibrillation
(3)
+
-
GLORIA-AF
(3)
+
-
atrial fibrillation
(3)
+
-
Anticoagulation
(2)
+
-
Dabigatran
(2)
+
-
Stroke
(2)
+
-
oral anticoagulation
(2)
+
-
stroke prevention
(2)
+
-
Show more
Author
Diener, H.C.
(11)
+
-
Dubner, S.J.
(11)
+
-
Huisman, M.V.
(11)
+
-
Lip, G.Y.H.
(11)
+
-
Rothman, K.J.
(11)
+
-
Teutsch, C.
(11)
+
-
Zint, K.
(11)
+
-
Halperin, J.L.
(10)
+
-
Ma, C.S.
(10)
+
-
Paquette, M.
(9)
+
-
Lu, S.H.
(7)
+
-
Bartels, D.B.
(6)
+
-
Franca, L.R.
(5)
+
-
GLORIA-AF Investigators
(5)
+
-
Elsaesser, A.
(4)
+
-
Mazurek, M.
(4)
+
-
Brandes, A.
(2)
+
-
Show more
Language
en
(11)
+
-
Search results
(1 - 11 of 11)
show grid
show list
save search
Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation
Persistence with anticoagulation for atrial fibrillation
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program
Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program
Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation
The Changing Landscape for Stroke Prevention in AF Findings From the GLORIA-AF Registry Phase 2
Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: A global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation